benzothiadiazines

Preferred Label : benzothiadiazines;

MeSH definition : Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.;

Is substance : O;

Details

Origin ID

D001581;

UMLS CUI

C0005084;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Benzothiadiazine derivatives [Bloc CIM-11]
Currated CISMeF NLP mapping
- Benzothiadiazine (substance) [SNOMED CT concept]
Manual BTNT mappings - CISMeF
- Diuretic benzothiadiazine [ICD-11 Extension code]
Record concept(s)
- benzothiadiazines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2-(2,4,5-trifluorobenzyl)-7-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide-4-yl)acetic acid [MeSH Supplementary Concept]
- (2-(2,4,5-trifluorobenzyl)-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide-4-yl)acetic acid [MeSH Supplementary Concept]
- (2-(4-bromo-2-fluorobenzyl)-7-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide-4-yl)acetic acid [MeSH Supplementary Concept]
- 1,3,2,4-benzodithiadiazine [MeSH Supplementary Concept]
- 1-((4-chlorophenyl)methyl)-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide [MeSH Supplementary Concept]
- 1-benzyl-3-(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-dioxide [MeSH Supplementary Concept]
- 2,3,3a,4-tetrahydro-1H-pyrrolo(2,1-c)(1,2,4) benzothiadiazine 5,5-dioxide [MeSH Supplementary Concept]
- 2H-1,2,4-benzothiadiazine-1,1-dioxide [MeSH Supplementary Concept]
- 2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid [MeSH Supplementary Concept]
- 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide [MeSH Supplementary Concept]
- 3-amino-1,2,4-benzothiadi-azine 1,1-dioxide [MeSH Supplementary Concept]
- 4-(4H-1,2,4-benzothiadiazine-3-yl)-2,6-bis(dimethylethyl)phenol-S,S-dioxide [MeSH Supplementary Concept]
- 4-(6,7-dichloro-4H-1,2,4-benzothiadiazine-3-yl)-2,6-bis(1,1-dimethylethyl)phenol-S,S-dioxide [MeSH Supplementary Concept]
- 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 4-ethyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 6-aminomethyl-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 6-chloro-3-cyclobutylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 6-chloro-7-fluoro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 7-chloro-3-(1-hydroxy-2-propyl)amino-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 7-chloro-3-(3-pentylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 7-chloro-4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 7-chloro-9-(furan-3-yl)-2,3,3a,4-tetrahydro-1H-benzo(e)pyrrolo(2,1-c)(1,2,4)thiadiazine 5,5-dioxide [MeSH Supplementary Concept]
- 8-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- A 837093 [MeSH Supplementary Concept]
- BPDZ 154 [MeSH Supplementary Concept]
- DU 717 [MeSH Supplementary Concept]
- IDRA 21 [MeSH Supplementary Concept]
- N-(1-benzyl-3-(cyclopropylamino)-2-hydroxypropyl)-7-ethyl-1-methyl-3,4-dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2-dioxide [MeSH Supplementary Concept]
- QM 7184 [MeSH Supplementary Concept]
- RPR 104632 [MeSH Supplementary Concept]
- S18986-1 [MeSH Supplementary Concept]
- althiazide [MeSH Supplementary Concept]
- bemetizide, bupranolol, triamterene drug combination [MeSH Supplementary Concept]
- bemetizide, triamterene drug combination [MeSH Supplementary Concept]
- bentazone [MeSH Supplementary Concept]
- benzothiazide [MeSH Supplementary Concept]
- cyclothiazide [MeSH Supplementary Concept]
- cyclothiazide, triamterene drug combination [MeSH Supplementary Concept]
- dehydrosanol [MeSH Supplementary Concept]
- flumethiazide [MeSH Supplementary Concept]
- goe 4962 [MeSH Supplementary Concept]
- hypertane [MeSH Supplementary Concept]
- mebutizide [MeSH Supplementary Concept]
- paraflutizide [MeSH Supplementary Concept]
- penfluzide [MeSH Supplementary Concept]
- pipazethate [MeSH Supplementary Concept]
- setrobuvir [MeSH Supplementary Concept]
- tensigradyl [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients